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Abstract
Virus-like particle (VLP) formation by the coronavirus E and M proteins suggests that interactions between these proteins play a critical
role in coronavirus assembly. We studied interactions between the infectious bronchitis virus (IBV) E and M proteins using in vivo
crosslinking and VLP assembly assays. We show that IBV E and M can be crosslinked to each other in IBV-infected and transfected cells,
indicating that they interact. The cytoplasmic tails of both proteins are important for this interaction. We also examined the ability of the
mutant and chimeric E and M proteins to form VLPs. IBV M proteins that are missing portions of their cytoplasmic tails or transmembrane
regions were not able to support VLP formation, regardless of their ability to be crosslinked to IBV E. Interactions between the E and M
proteins and the membrane bilayer are likely to play an important role in VLP formation and virus budding.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
Enveloped viruses acquire their lipid membranes from
those of the host cell in a process known as budding, in
which the virus envelope proteins accumulate at the appro-
priate membrane and cooperate with the nucleocapsid and
other viral components to induce membrane curvature and
pinching (Garoff et al., 1998). Most well-studied enveloped
viruses, such as influenza and retroviruses, bud from the
plasma membrane of cells, which results in the release of
virus particles from the host cell as soon as the pinching
process is complete. However, the envelopes of other vi-
ruses are derived by budding into the lumen of intracellular
secretory compartments, such as the endoplasmic reticulum
(ER) and Golgi apparatus (Griffiths and Rottier, 1992).
Intracellular budding is a seemingly more complex way of
obtaining a lipid envelope, since virus particles are con-
tained within intracellular membrane-bound compartments
as a result of budding. The newly budded viruses presum-
ably exploit the cellular secretory pathway to exit the cell
for a new round of infection. The reasons that some envel-
oped viruses have evolved to bud inside the cell are not
known. Several clinically important viruses bud into intra-
cellular membranes. Viruses of the family Flaviviridae,
which include hepatitis C virus and Kunjin virus, derive
their lipid envelopes by budding into the lumen of the ER
(Dubois-Dalcq et al., 1984; Mackenzie and Westaway,
2001). As another example, the hemorrhagic fever-causing
Hantaviruses, members of the family Bunyaviridae, bud
into the membranes of the Golgi complex (Hung et al.,
1985; Pettersson, 1991). The advantage provided by intra-
cellular budding remains an interesting and important ques-
tion in the biology of these and other viruses that obtain
their envelopes from intracellular membranes.
Coronaviruses are positive-stranded RNA viruses that
acquire their membrane envelope by budding into the lumen
of a pre-Golgi compartment or cis-Golgi network (CGN)
(Klumperman et al., 1994). Accumulating evidence indi-
cates that the E and M proteins are instrumental in this
process. Rottier and colleagues made the initial observation
that mouse hepatitis virus (MHV) E and M proteins are
sufficient to produce membrane-bound particles very simi-
lar to virions in size and shape (Vennema et al., 1996), and
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this result has been confirmed with the E and M proteins of
several other coronaviruses (Baudoux et al., 1998; Corse
and Machamer, 2000; Godeke et al., 2000). These observa-
tions suggest that coronavirus budding is directed by enve-
lope proteins alone, which is an unusual type of enveloped
virus assembly (Garoff et al., 1998). The coronavirus E
protein appears to play a critical role in the budding step,
since mutations introduced into the cytoplasmic tail of
MHV E by targeted RNA recombination result in elongated
virions (Fischer et al., 1998). Indeed, it has been shown that
both the MHV E and the infectious bronchitis virus (IBV) E
proteins are sufficient for formation of the virus-like parti-
cles (VLPs) described above (Corse and Machamer, 2000;
Maeda et al., 1999), although the efficiency probably varies
with cell type and protein expression system.
We are interested in understanding the mechanisms by
which the avian coronavirus IBV selects a bud site and
assembles in CGN membranes. We have previously shown
that the IBV M and E proteins independently localize to the
Golgi region of transfected cells (Corse and Machamer,
2000; Machamer and Rose, 1987) and characterized the
Golgi targeting signals in the two proteins that direct this
localization (Corse and Machamer, 2002; Machamer et al.,
1993). In the study described here, we examined interac-
tions between the IBV E and M proteins in transfected
OST7-1 cells using the chemical crosslinker dithiobis[suc-
cinimidyl propionate] (DSP). Using mutant E and M pro-
teins that are correctly targeted to the Golgi complex, we
found that the cytoplasmic tails of both proteins are required
for their interaction. We found that IBV E and M proteins
can be efficiently assembled into VLPs in OST7-1 cells, and
we investigated which domains of IBV E and M are re-
quired for this process. Interestingly, the interaction of M
and E, as measured by crosslinking, was not sufficient for
VLP formation. It is likely that interactions of E and M with
each other as well as the membrane bilayer are important for
VLP formation and virus budding.
Results
IBV E and M proteins colocalize in the Golgi region and
interact in IBV-infected cells
Although the IBV E protein is distributed throughout the
Golgi stack when expressed alone (Corse and Machamer,
2000, 2001), the IBV E and M proteins exactly colocalize in
IBV-infected Vero cells examined by indirect immunoflu-
orescence at early times postinfection (Fig. 1A). We wanted
to investigate the possibility that this precise colocalization
was indicative of a physical interaction between the two
proteins. Since attempts to coimmunoprecipitate E and M
proteins from IBV-infected Vero cells in a variety of deter-
gent conditions were unsuccessful, we employed the cell-
permeable chemical crosslinker DSP, which is a thiol-cleav-
able molecule that contains two amine-reactive groups
separated by a 12 Å spacer arm. IBV-infected Vero cells
were radiolabeled at 45 h postinfection and treated with
DSP prior to lysis and immunoprecipitation with anti-E or
anti-M antibodies. When we analyzed the immunoprecipi-
tates by SDS–PAGE, we found that M was present in the
anti-E immunoprecipitations and vice versa (Fig. 1B, lanes
4 and 8). This association was dependent on the presence of
DSP since it was not seen in samples that were mock-treated
(lanes 2 and 6). Immunoprecipitation with irrelevant anti-
bodies yielded no visible bands (not shown). In the absence
of -mercaptoethanol, which cleaves the disulfide bond of
DSP, the unseparated crosslinked E and M proteins were
present as high molecular weight aggregates and migrated at
a high position on the gel (not shown). The crosslinking and
coimmunoprecipitation was not quantitative, since only a
fraction of the total E protein (as measured by the amount of
E in the anti-E immunoprecipitation) was found in the
anti-M immunoprecipitation. This could be due to the in-
herent inefficiency of chemical crosslinking. Alternatively,
this result could reflect the small E:M ratio in virions (Liu
Fig. 1. IBV E and M colocalize and interact in IBV-infected Vero cells. (A)
IBV-infected Vero cells were fixed for immunofluorescence at 6 h postin-
fection and double labeled with rat anti-E antibody (a) and rabbit anti-M
antibody (b). Secondary antibodies were fluorescein-conjugated goat anti-
rat IgG and Texas red conjugated donkey anti-rabbit IgG. Panel c is a
differential interference contrast (DIC) image of the labeled cells. Bar, 15
m. (B) IBV-infected Vero cells were labeled with [35S]methionine-cys-
teine at 45 h postinfection, treated with DSP as indicated, lysed, and
immunoprecipitated with anti-E or anti-M antibodies as described under
Materials and methods. The immunoprecipitates were analyzed by SDS–
15% PAGE, in the presence or absence of -mercaptoethanol (ME) as
indicated, and fluorography. IBV E is coprecipitated with IBV M after
crosslinking and vice versa. These data are representative of at least three
independent experiments.
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and Inglis, 1991), which is presumably determined by the
stoichiometry of envelope protein interactions. We con-
clude that the IBV E and M proteins interact in infected
cells.
IBV E and M proteins directly interact when expressed in
the absence of a virus infection
IBV-infected cells contain other viral proteins which
might be required for interaction of E and M. To determine
if the IBV E and M proteins could interact directly, we
coexpressed them in OST7-1 cells. We used indirect immu-
nofluorescence to verify coexpression and correct intracel-
lular localization of the two proteins (Fig. 3A, panels a–c).
As expected, the IBV E and M proteins colocalized in a
compact perinuclear region characteristic of the Golgi com-
plex in this cell type, as seen previously in BHK-21 cells
(Corse and Machamer, 2000). When we treated OST7-1
cells coexpressing IBV E and M with DSP and analyzed
anti-E and anti-M immunoprecipitates as described above,
we found that M protein was present in the anti-E immu-
noprecipitate (Fig. 2, lane 4) and that E protein was present
in the anti-M immunoprecipitate (Fig. 2, lane 8), suggesting
that the two proteins directly interact in transfected cells.
Detection of the interaction required crosslinking (compare
lanes 3 and 7 to lanes 4 and 8) and antisera specific for E or
M. Even though less E was expressed in transfected cells
(Fig. 2) compared to IBV-infected cells (Fig. 1B), the ratio
of E:M crosslinks (as seen in the relative amounts of E and
M in the anti-M and anti-E immunoprecipitations, respec-
tively) was similar, suggesting that there is a precise stoi-
chiometry of interaction.
To investigate which domains of the E and M proteins
interact, we made use of a panel of mutant E and M proteins
that were generated to study the Golgi targeting signals
present in the two proteins (Corse and Machamer, 2002;
Machamer and Rose, 1987). Although many mutant E and
M proteins have been generated, in this study, we used only
those that are properly targeted to the Golgi region. Since
these mutant proteins had previously been localized in
BHK-21 or COS-7 cells, we first confirmed that they were
properly targeted in OST-7 cells. Cells coexpressing wild-
type M protein and E mutants were analyzed by indirect
immunofluorescence microscopy (Fig. 3A). EG3 (panels
d–f) contains the transmembrane domain from the plasma
membrane protein vesicular stomatitis virus (VSV) G; CTE
(panels g–i) is an N-terminal truncation of IBV E consisting
only of its cytoplasmic tail, and GEt (panels j–l) is a chi-
meric protein containing the lumenal and transmembrane
domains of VSV G and the cytoplasmic tail of IBV E. In all
cases, the E mutant proteins were correctly localized to the
Golgi region of OST7-1 cells (including the partial trans-
membrane replacement mutants EG1 and EG2, not shown),
consistent with our previous studies in BHK-21 cells (Corse
and Machamer, 2002). Fig. 3B shows cells that are coex-
pressing wild-type E protein and the M protein deletion
mutants Mct1 (panels a–c), which is missing cytoplasmic
tail amino acid residues 103–203, Mct2 (panels d–f),
which is missing cytoplasmic tail residues 119–203, Mct3
(panels g–i), which is missing cytoplasmic tail residues
103–118, or Mm2,3 (panels j–l), which is missing the
second and third transmembrane domains (amino acid res-
idues 43–101). The M mutants, especially Mct3 (Fig. 3B,
panel h) and Mm2,3 (Fig. 3B, panel k), were incompletely
localized to the Golgi region, since some ER staining was
observed. However, they all reached the Golgi to some
extent, as indicated by the juxtanuclear spot.
The cytoplasmic tail of IBV E is sufficient for its
interaction with IBV M
We asked whether the E transmembrane replacement
mutants EG1, EG2, and EG3 (in which the first third, the
first two-thirds, or the entire E transmembrane domain,
respectively, were replaced with the corresponding regions
of the VSV G transmembrane domain) (Corse and Macha-
mer, 2002) could be crosslinked to wild-type M protein. The
appropriate proteins were coexpressed and immunoprecipi-
tated with anti-E or anti-M antibodies after treating the cells
with DSP as described above (Fig. 4A). All three E trans-
membrane replacement mutants were crosslinked to M pro-
tein, suggesting that the E transmembrane domain is not
required for E and M interaction. However, there was less
M in the anti-E immunoprecipitation of EG3 (Fig. 4A, lane
4), suggesting that the interaction of M with this mutant
could be decreased. Perhaps the E and M transmembrane
domains interact, or the conformation of the cytoplasmic
Fig. 2. IBV E and M interact in transfected OST7-1 cells. OST7-1 cells
expressing E and M proteins alone or together were labeled with [35S]me-
thionine-cysteine, treated with DSP as indicated, lysed, and immunopre-
cipitated with anti-E or anti-M antibodies as described under Materials and
methods. All immunoprecipitates in this and the following figures were
deglycosylated by treating with N-glycanase to collapse the M protein to a
single band. The immunoprecipitates were analyzed by SDS–17.5% PAGE
in the presence of ME, and fluorography. The asterisk indicates a band
that corresponds to M protein dimers. These data are representative of at
least three independent experiments.
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tail of E is altered when the complete transmembrane do-
main is replaced (see below).
To evaluate the role of the E cytoplasmic tail in interac-
tion with M, we tested whether the chimeric protein GEt
(which consists of the cytoplasmic tail of IBV E and the
transmembrane and lumenal domains of VSV G; see Fig.
3A) could be crosslinked to M (Fig. 4B). As shown in Fig.
4B, lane 1, M was found in the immunoprecipitation with
anti-E antibody, which recognizes the last 14 amino acids of
Fig. 3. The wild-type and mutant versions of IBV E and IBV M proteins
used in this study are localized to the Golgi region of transfected OST7-1
cells. (A) OST7-1 cells expressing wild-type IBV E and M proteins (a–c),
EG3 and wild-type M protein (d–f), CTE and wild-type M protein (g–i), or
GEt and wild-type M protein (j–l) were fixed for immunofluorescence and
double labeled with rat anti-E antibody (a, d, g, and j) and rabbit anti-M
antibody (b, e, h, and k). Secondary antibodies were fluorescein-conjugated
goat anti-rat IgG and Texas red conjugated donkey anti-rabbit IgG. The
third image in each row (c, f, i, and l) is a DIC image of the labeled cells.
In the diagrams of the E mutant and chimeric proteins, IBV E sequence is
shown in black and VSV G sequence is shown in gray. Bar, 10 m. (B)
OST7-1 cells expressing wild-type E protein and Mct1 (a–c), Mct2
(d–f), Mct3 (g–i), or Mm2,3 (j–l) were fixed for immunofluorescence
and double labeled with rat anti-E antibody (a, d, g, and j) and rabbit anti-M
antibody (b, e, h, and k). Secondary antibodies were fluorescein-conjugated
goat anti-rat IgG and Texas red conjugated donkey anti-rabbit IgG. The
third image in each row (c, f, i, and l) is a DIC image of the labeled cells.
In the diagrams of the deletion mutant M proteins, the thin lines indicate
deleted sequence. Bar, 10 m.
Fig. 4. The cytoplasmic tail of IBV E is sufficient for interaction with IBV
M. (A) OST7-1 cells expressing wild-type M protein and wild-type E
protein or the E transmembrane replacement mutant proteins EG1, EG2, or
EG3 were labeled with [35S]methionine-cysteine, treated with DSP, lysed,
and immunoprecipitated with anti-E or anti-M antibodies as described
under Materials and methods. The immunoprecipitates were analyzed by
SDS–17.5% PAGE in the presence of ME, and fluorography. The asterisk
indicates a band that corresponds to M protein dimers. (B) OST7-1 cells
coexpressing the GEt chimera and wild-type M protein were labeled with
[35S]methionine-cysteine, treated with DSP, lysed, and immunoprecipi-
tated with anti-E or anti-M antibodies as described under Materials and
methods. The immunoprecipitates were analyzed by SDS–15% PAGE in
the presence of ME, and fluorography. The asterisk indicates a band that
corresponds to M protein dimers. (C) OST7-1 expressing CTE protein
alone or with M protein were labeled with [35S]methionine-cysteine,
treated with DSP, lysed, and immunoprecipitated with anti-E antibodies as
described under Materials and methods. The immunoprecipitates were
analyzed by SDS–17.5% PAGE in the presence of ME, and fluorography.
These data are representative of at least three independent experiments.
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the E cytoplasmic tail and thus the GEt chimera. The recip-
rocal immunoprecipitation with anti-M antibody contained
GEt protein (lane 3). We conclude that the cytoplasmic tail
of IBV E protein is sufficient for interaction with M protein.
Indeed, the N-terminal truncation mutant CTE, which con-
sists only of the cytoplasmic tail of IBV E (Corse and
Machamer, 2002), was coprecipitated with M after
crosslinking (Fig. 4C, lane 2). We previously found that
partial or complete removal of a 50 amino acid region
within the 80 amino acid E cytoplasmic tail resulted in
transport of the GEt chimera to the cell surface (Corse and
Machamer, 2002). Therefore, we did not attempt to find a
specific region within the IBV E cytoplasmic tail that inter-
acts with IBV M, because colocalization of the IBV E and
M proteins is likely to be required for their interaction.
The IBV M cytoplasmic tail is required for crosslinking to
IBV E
To determine which regions of the IBV M protein were
involved in interaction with IBV E, we tested how well the M
deletion mutants Mct1, Mct2, Mct3, and Mm2,3 could
be crosslinked to wild-type E protein compared to wild-type M
protein (Fig. 5). Mm2,3 is missing the second and third
transmembrane domains of IBV M; since it was crosslinked to
E protein as well as wild-type M (lanes 5 and 10), we conclude
that these membrane- spanning regions are not involved in
interactions with E. A large portion of the M cytoplasmic tail
is deleted in Mct1 (see Fig. 3B), and this protein was not
crosslinked efficiently to E, compared to wild-type M protein
(Fig. 5, lanes 2 and 7), although a small amount of E protein is
visible in the Mct1 immunoprecipitation (Fig. 5, lane 7). This
result indicates that the M cytoplasmic tail is involved in
interaction with E. The portion of the M cytoplasmic tail
removed by the Mct1 deletion is split into parts by the Mct2
and Mct3 deletions. Note that the Mct1 and Mct2 mutants
are not radiolabeled as efficiently as wild-type M and the
Mct3 and Mm2,3 mutants (compare lanes 7 and 8 with lane
6) because they have fewer methionines and cysteines due to
their deletions, which could explain why a reciprocal amount
of Mct1 is not seen in the anti-E immunoprecipitation (Fig. 5,
lane 2). Mct3, which is missing amino acids 103–118 of the
M cytoplasmic tail, was crosslinked to E (Fig. 5, lanes 4 and 9),
while Mct2, which is missing amino acids 119–203 of the M
cytoplasmic tail (see Fig. 2B), was not (Fig. 5, lanes 3 and 8).
This indicates that the amino acids removed by the Mct2
deletion (119–203) are required for crosslinking of the IBV M
protein to the IBV E protein.
The transmembrane domain of IBV E is not required for
VLP formation
The E and M proteins of several coronaviruses are re-
leased from cotransfected cells in membrane-bound parti-
cles that are morphologically similar to virions (VLPs),
suggesting that interactions between these proteins are an
integral part of coronavirus assembly (Baudoux et al., 1998;
Corse and Machamer, 2000; Godeke et al., 2000; Vennema
et al., 1996). We initially attempted to study VLPs formed
in BHK cells from IBV E and M proteins expressed by
coinfection with recombinant vaccinia viruses encoding
each protein. However, we found that VLP formation was
extremely inefficient under these conditions and estimated
that only 0.01% of the cellular E and M proteins were
released into the supernatant as VLPs (Corse and Macha-
mer, 2000). Since we were interested in using VLP forma-
tion to delineate portions of the IBV E and M proteins that
are important in virus assembly, we employed the expres-
sion system used by Rottier and colleagues in their initial
description of MHV VLPs (Vennema et al., 1996). These
authors infected OST7-1 cells (Elroy-Stein and Moss,
1990), which are osteosarcoma cells that stably express
phage T7 RNA polymerase, with a vaccinia virus encoding
T7 polymerase (vTF7-3) (Fuerst et al., 1986) to provide
higher levels of T7 RNA polymerase. They then transfected
the cells with plasmids encoding MHV E and M behind the
T7 promoter. When we expressed the IBV E and M proteins
this way, we found that VLPs were formed efficiently (Fig.
6, lanes 3 and 14). The supernatant side of the gel (lanes
12–22) shown in this figure was exposed 20 times longer
than the cell side to allow the visualization of E and E
transmembrane mutant proteins (lanes 1–11). We have con-
sistently observed at least 10%, and frequently more, of the
cellular M protein being released into the supernatant during
the 3 h chase (data not shown). This level of VLP release
was dependent on E protein, since less than 1% of the
cellular M protein was found in the supernatant in the
absence of E. E protein was not visualized in the superna-
tants when expressed alone (Fig. 6, lane 12). We believe
that a small amount of E is released into the supernatant
Fig. 5. A region of the IBV M cytoplasmic tail is required for crosslinking
to IBV E. OST7-1 cells expressing wild-type E protein and wild-type M
protein or the M deletion mutant proteins Mct1, Mct2, Mct3, or
Mm2,3 were labeled with [35S]methionine-cysteine, treated with DSP,
lysed, and immunoprecipitated with anti-E or anti-M antibodies as de-
scribed under Materials and methods. The immunoprecipitates were ana-
lyzed by SDS–17.5% PAGE in the presence of ME, and fluorography.
The asterisks indicate bands that correspond to M, Mct3, or Mm2,3
protein dimers. These data are representative of at least three independent
experiments.
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when it is expressed alone, and that it is simply not visual-
ized unless a large amount of supernatant is loaded on the
gel, as in our previous experiments (Corse and Machamer,
2000). Our results differ from the data of Makino and
colleagues, who observed a substantial amount of MHV E
being released into the supernatant when expressed by itself
(Maeda et al., 1999); this discrepancy could be explained by
the different expression system used to produce the E pro-
tein in their study. We favor the hypothesis that VLP for-
mation involves a lattice of M protein within the membrane
with curvature induced by small amounts of the E protein
(De Haan et al., 2000) (see Discussion). This would account
for the small amount of IBV E protein relative to IBV M
protein that is found in VLPs.
We found that the partial or complete replacement of the
IBV E transmembrane domain (mutants EG1, EG2, and
EG3) had no effect on E’s ability to induce VLPs as mea-
sured by the amount of IBV M protein released into the
supernatant (Fig. 6, compare the M protein bands in lanes
14, 16, 18, and 20). We did notice that more EG2 and EG3
proteins were incorporated into VLPs compared to wild-
type E and EG1 proteins (Fig. 6, compare the E protein
bands in lanes 18 and 20 with those in lanes 14 and 16). It
is possible that conformational changes induced by replace-
ment of the transmembrane domain facilitates increased
incorporation of these mutants into VLPs. The EG2 and
EG3 mutants did not induce VLPs more efficiently than
wild-type E, because an increased amount of M protein was
not released into the supernatant.
We examined the ability of the E cytoplasmic tail to
induce VLPs by using the chimeric protein GEt. When
expressed by itself, we observed that a negligible amount of
this protein was released into the supernatant (Fig. 6, lane
21; recall that the supernatant side of the gel was exposed 20
times longer than the cell side) and that expression of GEt
with IBV M did not increase the amount of M that was
released when M was expressed alone (Fig. 6, lanes 22 and
13). We conclude that the GEt chimera does not induce
VLPs. Since both the EG3 and the GEt chimeras contain the
transmembrane domain of VSV G and the cytoplasmic tail
of IBV E, it seems likely that the VSV G lumenal domain
is incompatible with VLP formation, either because it is too
large or because it cannot be incorporated into the M protein
lattice for some other reason (see Discussion). Thus, it is
difficult to predict if the E cytoplasmic tail alone is capable
of inducing VLPs. We also did not observe VLP formation
with the IBV E N-terminal truncation mutant CTE, which
consists only of the E cytoplasmic tail (data not shown).
However, this result is inconclusive since the CTE protein is
less stable than wild-type E protein and thus accumulates to
significantly lower levels (Corse and Machamer, 2002).
VLP formation with mutant IBV M proteins does not
correlate with crosslinking to IBV E
We evaluated the incorporation of the IBV M deletion
mutants Mct1, Mct2, Mct3, and Mm2,3 into VLPs.
As shown in Fig. 7, none of the deletion mutants were able
to support VLP formation at a detectable level, regardless of
whether they could be crosslinked to IBV E. The Mct1 and
Mct2 mutants are not radiolabeled as efficiently as wild-
type M and the Mct3 and Mm2,3 mutants (compare
lanes 5,6,7, and 8 with lanes 2 and 3) because they have
fewer methionines and cysteines due to their deletions.
However, we would still expect to see a detectable signal in
the supernatants after a long exposure if these mutants
supported VLP formation at a level comparable to wild-type
Fig. 6. Complete replacement of the E transmembrane domain does not affect VLP formation. OST7-1 cells expressing the indicated proteins were labeled with
[35S]methionine-cysteine for 1 h and chased for 3 h, and the supernatants and cells were harvested and immunoprecipitated with anti-E and anti-M antibodies as
described under Materials and methods. The immunoprecipitates were analyzed by SDS–17.5% PAGE and fluorography. The supernatant samples (lanes 12–22)
were exposed to film 20 times longer than the cell samples (lanes 1–11) to allow the visualization of EG2 and EG3 proteins in lanes 18 and 20, respectively. The
asterisk indicates a band that corresponds to dimers of M protein. These data are representative of at least three independent experiments.
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M. Since we have never seen such a signal, we conclude
that these mutants do not support VLP formation.
These results indicate that both the cytoplasmic tail and
the transmembrane regions of IBV M are involved in VLP
formation, which is consistent with the results of Rottier and
colleagues, who found that mutations in all domains of the
MHV M protein abrogated VLP formation (De Haan et al.,
1998). These results suggest that a direct interaction be-
tween IBV E and M proteins is not sufficient for VLP
formation and that this process may depend on how the two
proteins interact with the membrane bilayer, both separately
and together.
Discussion
We have demonstrated an interaction between the IBV E
and M proteins using both in vivo chemical crosslinking and
VLP formation as assays. Using IBV E and M protein
mutants that were generated in the course of Golgi targeting
studies, we examined the domains in the IBV E and M
proteins that are involved in their interaction. We found that
the cytoplasmic tails of both proteins mediate their interac-
tion, as measured by crosslinking. Interestingly, however,
we observed that reciprocal crosslinking of IBV E and M
protein mutants did not correlate with VLP formation, sug-
gesting that interaction between IBV E and M is not suffi-
cient for VLP formation. Here we compare our results to
those reported by other groups and discuss the implications
of our findings for coronavirus assembly.
Cytoplasmic tail of IBV E and its interaction with IBV M
Lim and Liu previously used a coimmunoprecipitation
assay to detect IBV E and M protein interactions (Lim and
Liu, 2001). They also concluded that the cytoplasmic tail of
IBV E is important for interaction with IBV M, since dele-
tion of a 20 amino acid region within the E cytoplasmic tail
(amino acids 37–57) prevented coimmunoprecipitation of
the E and M proteins and VLP formation. As mentioned
above, we did not attempt to find a region within the E tail
that mediates its interaction with IBV M, because we pre-
viously found that partial or complete replacement of a 50
amino acid region in the IBV E tail results in transport of a
reporter chimera from the Golgi complex to the cell surface,
which indicates that the cytoplasmic tail of E contains Golgi
targeting information (Corse and Machamer, 2002). Our
subcellular localization results differ from those of Lim and
Liu, who reported that IBV E is localized to the endoplas-
mic reticulum of transfected cells (Lim and Liu, 2001),
possibly because they examined cells overexpressing
epitope-tagged IBV E protein.
Coronavirus M protein and VLP formation
The M protein is by far the most abundant envelope
protein of coronaviruses and has been estimated to account
for 40% of the mass of IBV and MHV particles (Stern et
al., 1982; Sturman et al., 1980). Thus the physical nature of
the coronavirus envelope must be largely determined by the
characteristics of the M protein. Interestingly, however, the
M protein cannot drive coronavirus budding by itself, but
displays a strict requirement for a small amount of E protein
for VLP formation (Baudoux et al., 1998; Corse and Macha-
mer, 2000; Godeke et al., 2000; Vennema et al., 1996). We
have observed this low E protein:M protein ratio in IBV
VLPs (Fig. 6, lane 14); measurements of the amount of E
and M proteins in IBV virions also reveal a relatively low
amount of E protein (Liu and Inglis, 1991). We favor the
hypothesis that VLP formation involves a specific mem-
brane curvature that is induced by the proper ratio of M and
E proteins. The mechanism by which a small amount of E
protein interacts with a large amount of M protein to induce
invagination and pinching of the membrane to form VLPs
Fig. 7. Cytoplasmic and transmembrane region deletion mutants of IBV M do not support VLP formation. OST7-1 cells expressing the indicated proteins
were labeled with with [35S]methionine-cysteine for 1 h and chased for 3 h, and the supernatants and cells were harvested and immunoprecipitated with anti-E
and anti-M antibodies as described under Materials and methods. The immunoprecipitates were analyzed by SDS–17.5% PAGE and fluorography. The
supernatant samples (lanes 12–22) were exposed to film 13 times longer than the cell samples (lanes 1–11). The Mct1 and Mct2 mutants are not
radiolabeled as efficiently as wild-type M and the Mct3 and Mm2,3 mutants because they have fewer methionines and cysteines due to their deletions.
These data are representative of at least three independent experiments.
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remains unclear, but its elucidation is likely to be essential
for a complete understanding of coronavirus assembly. Sev-
eral studies have addressed the question of how the coro-
navirus E and M proteins interact in VLP formation.
Rottier and colleagues (De Haan et al., 1998) studied the
primary sequence requirements for incorporation of the
MHV M protein into VLPs. They found that all regions of
MHV M seem to be important for VLP formation, since
mutations in the short lumenal domain, the transmembrane
region, and the cytoplasmic tail all impaired VLP formation
to some extent. These results are consistent with our obser-
vation that deletions in both the cytoplasmic and the trans-
membrane domains of IBV M prevent VLP formation.
Interestingly, the extreme C-terminus of the cytoplasmic tail
MHV M was found to be especially important, since dele-
tion of only the C-terminal threonine residue prevented VLP
formation (De Haan et al., 1998). We were unable to ex-
amine the role of the extreme C-terminus of the IBV M
protein in VLP formation because our antibody to IBV M
recognizes this sequence.
Laude and colleagues (Baudoux et al., 1998) showed that
coexpression of the E and M proteins of transmissible gas-
troenteritis virus (TGEV) and of bovine coronavirus (BCV)
resulted in VLP production. In this study VLPs were also
produced with a BCV- TGEV chimeric M protein. Interest-
ingly, the chimeric M protein was able to form VLPs with
TGEV E, BCV E, and BCV-TGEV chimeric E proteins.
Since TGEV and BCV are in different coronavirus groups
based on serological and genomic sequence relationships,
this suggests that VLP formation does not depend on inter-
actions between E and M proteins that are based on strict
sequence requirements. Well-conserved three- dimensional
characteristics of the E and M proteins may be instrumental
in VLP formation.
Crosslinking of IBV E and M protein mutants is not
sufficient for VLP formation
Our results suggest that VLP formation involves more than
an interaction between E and M proteins, since M protein
mutants that could be crosslinked to E protein (Mct3 and
Mm2,3; see Fig. 5) are not incorporated into virus-like par-
ticles. It is possible that VLP formation requires interactions
between M proteins, as proposed by Rottier and colleagues (De
Haan et al., 2000). These workers demonstrated homotypic
interactions among MHV M protein molecules by coimmuno-
precipitation and incorporation of VLP assembly-incompetent
MHV M mutants into VLPs via their interaction with assem-
bly-competent MHV M proteins. These authors hypothesize
that the VLP (and virion) envelope mainly consists of an M
protein lattice, with a few E proteins interspersed within this
lattice. Although we have not examined whether homotypic
interactions between IBV M proteins exist, we think it possible
that such interactions may be important in IBV VLP assembly.
We did observe a small amount of SDS-resistant IBV M
protein dimers in our anti-M immunoprecipitations (indicated
by asterisks in Figs. 2, 4, 5, and 6), although we have no direct
evidence that these dimers are physiologically relevant.
We also showed that the GEt chimera could be
crosslinked to IBV M protein (Fig. 4B), but did not induce
VLP formation (Fig. 6). Since the GEt chimera contains the
same transmembrane domain and cytoplasmic tail as the
transmembrane replacement mutant EG3, which was able to
induce VLP formation as well as wild-type E protein (Fig.
6), a likely explanation is that the VSV G ectodomain
prevents induction of VLPs. One possibility is that this large
ectodomain does not fit well into the lattice of M protein in
the membrane. A similar observation was reported by Rot-
tier and colleagues (De Haan et al., 2000), who showed that
foreign proteins such as wild-type VSV G protein, equine
arteritis virus M protein, and CD8 were effectively excluded
from MHV VLPs. Likewise, it is possible that the M dele-
tion mutants we tested in the VLP assay are not in the right
conformation to fit into such a lattice of M protein, and thus,
do not support VLP formation.
The role of the IBV E cytoplasmic tail in interaction with
both IBV M and Golgi targeting
As mentioned above, we have previously shown that the
cytoplasmic tail of the IBV E protein is sufficient to localize
it to the Golgi complex and to mediate its redistribution with
the Golgi scaffold proteins GM130 and p115 during brefel-
din-A treatment (Corse and Machamer, 2002). Since these
and other Golgi scaffold proteins are known to be part of a
complex which is thought to mediate vesicle tethering dur-
ing intra-Golgi transport (Barr et al., 1998; Seemann et al.,
2000a,b), this led us to hypothesize that the IBV E protein
may be targeted to the Golgi apparatus via a direct interac-
tion with one or more Golgi scaffold proteins. Furthermore,
interaction of IBV E with the Golgi scaffold could result in
modulation of vesicular traffic, which might be advanta-
geous for collecting coronavirus envelope proteins in a
specific Golgi compartment for assembly (Corse and
Machamer, 2002).
Since we have shown here that the cytoplasmic tail of
IBV E is also important for interactions with IBV M, this
raises the question of whether the E cytoplasmic tail can
interact with M and the Golgi scaffold simultaneously. If
not, then it is possible that two functional pools of IBV E
protein exist in an infected cell. One pool could interact with
IBV M and the membrane at the assembly site to induce
virus budding, while the other could associate with the
Golgi scaffold to influence vesicular traffic through the
Golgi complex. The latter interaction might aid in collecting
viral membrane proteins for assembly at Golgi membranes.
Since the small amount of IBV E protein found in virions
(Liu and Inglis, 1991) and VLPs (shown here) suggests that
not much E protein is required to induce virus budding,
maybe a second function of E protein, such as modulation of
Golgi transport, accounts for the apparent excess of IBV E
protein in infected cells (Corse and Machamer, 2000).
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Materials and methods
Cells and viruses
OST7-1 cells (Elroy-Stein and Moss, 1990) and Vero
cells were maintained in Dulbecco’s modified Eagle’s me-
dium (DMEM) containing 10% fetal calf serum (FCS) and
antibiotics. The adaptation of IBV (Beaudette strain) to
Vero cells has been described (Machamer and Rose, 1987).
The recombinant vaccinia viruses encoding phage T7 poly-
merase (vTF7-3), IBV M (vvIBVM), and wild-type and
mutant versions of IBV E (vvIBVE, vvEG3, vvCTE) have
been described (Corse and Machamer, 2000, 2002; Fuerst et
al., 1986; Machamer and Rose, 1987). Growth and titering
of recombinant vaccinia viruses were done as described
(Weisz and Machamer, 1994).
Expression plasmids
The pBS/IBV E, pBS/EG1, pBS/EG2, pBS/EG3, pBS/
GEt, pAR/M and pAR/Mm2,3 plasmids have been de-
scribed (Corse and Machamer, 2000, 2002; Machamer and
Rose, 1987). IBV M was subcloned into the BamHI site of
pT7/T3-18 (BRL) to create pT7/M. The M cytoplasmic tail
deletion mutant plasmids pAR/Mct1, pAR/Mct2, and
pAR/Mct3 were constructed by oligonucleotide-directed
mutagenesis as described (Machamer and Rose, 1987).
Mct1 is missing amino acids 103–203, Mct2 is missing
amino acids 119–203, and Mct3 is missing amino acids
103–118. All three of these cytoplasmic tail deletion mu-
tants contain the IBV M C-terminal 22 amino acids that are
recognized by the polyclonal anti-M antibody (see Fig. 3B).
pAR/E and pAR/CTE were made by PCR addition of
BamHI sites at both ends of the E and CTE inserts. pBS/IBV
E and pBS/CTE (Corse and Machamer, 2002), respectively,
were used as templates for PCR. The BamHI-digested PCR
products were cloned into the BamHI site of pAR2529, and
subclones were screened for correct orientation by indirect
immunofluorescence. The pT7/Mc1, pT7/Mct2, and
pT7/Mct3 plasmids used in VLP experiments were made
by PCR addition of EcoRI and XbaI restriction sites, with
the corresponding AR plasmids as templates. The T7/
Mm2,3 plasmid used in VLP experiments was made by
subcloning the pAR/Mm2,3 BamHI fragment into the the
BamHI site of pT7/T3-18.
Antibodies
The polyclonal anti-M antibody and its affinity purifica-
tion for use in immunofluorescence has been previously
described (Machamer and Rose, 1987). The rat and rabbit
polyclonal antibodies to the C-terminal 14 amino acids of
IBV E have been reported (Corse and Machamer, 2000).
The rabbit anti-VSV polyclonal antibody used to immuno-
precipitate radiolabeled G and GEt proteins has been de-
scribed (Weisz et al., 1993). Texas red conjugated donkey
anti-rabbit immunoglobulin G (IgG) and fluorescein-conju-
gated goat anti-rat IgG were from Jackson ImmunoResearch
Laboratories, Inc. (West Grove, PA).
Immunofluorescence microscopy
Vero cells were plated in 35-mm dishes 1 day before
being infected with IBV (passage 12), as previously de-
scribed (Machamer and Rose, 1987). The cells were fixed in
3% paraformaldehyde in phosphate-buffered saline (PBS)
for 20 min at room temperature, permeabilized with 0.5%
Triton X-100, and stained as previously described (Swift
and Machamer, 1991) with rat anti-E antibody and rabbit
anti-M antibody. OST7-1 cells were plated on cover slips in
35-mm dishes 2 days before infection with vTF7-3,
vvIBVE, vvEG3, or vvCTE at a multiplicity of infection of
20. Adsorption was for 1 h at 37°C, and cells infected with
vTF7-3 were transfected with 5 g of each expression
plasmid using 20 l of Lipofectin (Invitrogen, Carlsbad,
CA) as directed by the manufacturer. At 3.5 to 4 h postin-
fection the cells were fixed and stained as described above.
Chemical crosslinking
OST7-1 cells were plated in 35-mm dishes 2 days before
being infected with vTF7-3 and transfected with the appropri-
ate constructs as described above. In samples transfected with
only a plasmid encoding IBV E or IBV M alone, an equal
amount of empty vector plasmid was added so that an equal
amount of plasmid DNA was added to all samples. At 4 h
postinfection, the cells were labeled with 100 Ci of 35S-
Promix (Amersham Pharmacia Biotech, Piscataway, NJ) in 0.5
ml methionine- and cysteine-free medium for 1 to 1.5 h at
37°C. Vero cells were plated in a 10-cm dish 1 day before
being infected with IBV and labeled at 45 h postinfection for
1 h at 37°C with 500 Ci of 35S-Promix. After being rinsed
twice in room temperature PBS, cells were scraped into PBS,
transferred to microfuge tubes, and the thiol-cleavable
crosslinker DSP (Pierce, Rockford, IL) was added to 1 mM
after being prepared just before use as a 20 mM stock solution
in DMSO. For mock DSP treatments an equivalent amount of
DMSO was added. The cells were incubated with DSP for 10
min at room temperature, and the DSP was quenched by
adding glycine to 40 mM. The cells were lysed in detergent
solution [62.5 mM EDTA, 50 mM Tris (pH 8), 0.4% deoxy-
cholate, 1% NP-40] containing protease inhibitors, and the
postnuclear supernatants were immunoprecipitated with the
appropriate antibodies in the presence of 0.2% SDS as de-
scribed (Machamer and Rose, 1987). Treatment of immuno-
precipitates with N-glycanase was as previously described
(Machamer et al., 1990). The samples were subjected to SDS–
PAGE in the presence of - mercaptoethanol (except for the
indicated samples in Fig. 1B) and the labeled proteins were
visualized by fluorography.
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Virus-like particles
Appropriate constructs were expressed in OST7-1 cells by
infection with vTF7-3 and transfection as described above. At
3 h postinfection the cells were shifted from 37 to 32°C for 1 h
and then radiolabeled at 32°C with 35S-Promix for 1 to 1.5 h as
described above. After labeling the cells were chased in 1 ml
of growth medium for 3 h at 32°C. The medium was micro-
centrifuged at 14,000 rpm for 20 min at 4°C to remove cellular
debris, and the supernatants were immunoprecipitated with rat
anti-E and rabbit anti-M antibodies in the presence of 1%
Triton X-100 and 0.2% SDS. The cells were harvested by
rinsing in PBS and lysing in detergent solution. The post-
nuclear supernatants were immunoprecipitated with anti-E and
anti-M antibodies in the presence of 0.2% SDS. The immuno-
precipitates were treated with N-glycanase as described
(Machamer et al., 1990).
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